Mikhail Blagosklonny is a professor of oncology at New York’s Roswell Park Cancer Institute. In his field, he studies cancer and aging. He received his M.D in internal medicine and his Ph.D in cardiology and experimental medicine from the First Pavlov State Medical University of St.Petersburg.
In 2002 he was appointed an associate professor of medicine at the New York Medical College in Valhalla, New York. He then took a position at Ordway Research Institute in Albany, New York as a senior scientist where he stayed until 2009, at which time he was appointed professor of oncology at Roswell Park Cancer Institute in Buffalo, New York.
According to Impact Journals, Mikhail Blagosklonny’s interest lie in cancer and cancer therapies that protect normal cells from damage. The aging process is also one of his interests in which he researches underlying mechanisms of aging and the anti-aging drugs.
Mikhail Blagosklonny has authored over 170 research articles and reviews and is the Founding Editor and Editor-in-Chief of Cell Cycle and Associate Editor of Cancer Biology & Therapy. International Journal of Cancer, Cell Death & Differentiation, American Journal of Pathology, and PLOS ONE as also among his editorial interests.
In regards to his research interests, these vary from clinical investigations, molecular and cellular biology. This also includes signal transduction of basic science into the new anticancer strategies. He has extended this into the pathways from cancer to aging, to reveal the potential targets for slowing down aging and age-related diseases.
His hypothesis of the role of TOR signaling in aging and cancer is in proposing a popular cancer drug, rapamycin, as a possible treatment for life extension. He is a passionate advocate for the rapamycin drug in the search for longevity.
According to the scientists of Roswell Park Cancer Center Dr. Mikhail Blagosklonny will ease the development of the methods of cancer therapy and prevention and the new anti-cancer strategies.
Research Gate revealed to us that Mikhail Blagosklonny shares his approaches and ideas in regards to protection of normal cells for the radiology and chemotherapy,and the specific tissue therapy and anti-tissue therapy of cancer. The selective combinations of anticancer drugs and the prevention of cancer by means of slowing down organismal aging are also among his research.